{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T20:43:53Z","timestamp":1693428233605},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/ncpgasthep1317","type":"journal-article","created":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T08:49:07Z","timestamp":1227602947000},"page":"57-60","source":"Crossref","is-referenced-by-count":7,"title":["A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone"],"prefix":"10.1038","volume":"6","author":[{"given":"Vu","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javid","family":"Fazili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"issue":"Suppl 1","key":"BFncpgasthep1317_CR1","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1002\/hep.510260720","volume":"26","author":"G Dusheiko","year":"1997","unstructured":"Dusheiko G (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26 (Suppl 1): S112\u2013S121","journal-title":"Hepatology"},{"key":"BFncpgasthep1317_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/archneur.1997.00550190093020","volume":"54","author":"SB Rutkove","year":"1997","unstructured":"Rutkove SB (1997) An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a. Arch Neurol 54: 907\u2013908","journal-title":"Arch Neurol"},{"key":"BFncpgasthep1317_CR3","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.3748\/wjg.v13.i40.5411","volume":"13","author":"H Elloumi","year":"2007","unstructured":"Elloumi H  et al. (2007) Sudden hearing loss associated with peginterferon and ribavarin combination therapy during hepatitis C treatment. World J Gastroenterol 13: 5411\u20135412","journal-title":"World J Gastroenterol"},{"key":"BFncpgasthep1317_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1365-2516.2000.00391.x","volume":"6","author":"O Ogundipe","year":"2000","unstructured":"Ogundipe O and Smith S (2000) Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with hemorrhagic disorders. Hemophilia 6: 110\u2013112","journal-title":"Hemophilia"},{"key":"BFncpgasthep1317_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s004010050740","volume":"94","author":"A Quattrini","year":"1997","unstructured":"Quattrini A  et al. (1997) Axonal neuropathy associated with interferon- treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol 94: 504\u2013508","journal-title":"Acta Neuropathol"},{"key":"BFncpgasthep1317_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","volume":"24","author":"G Fattovich","year":"1996","unstructured":"Fattovich G  et al. (1996) A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 24: 38\u201347","journal-title":"J Hepatol"},{"key":"BFncpgasthep1317_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1572-0241.2004.30372.x","volume":"99","author":"E Formann","year":"2004","unstructured":"Formann E  et al. (2004) Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon\/ribavirin. Am J Gastroenterol 99: 873\u2013877","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1317_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/00206099509071903","volume":"3","author":"Y Kanda","year":"1995","unstructured":"Kanda Y  et al. (1995) Interferon-induced sudden hearing loss. Audiology 3: 98\u2013102","journal-title":"Audiology"},{"key":"BFncpgasthep1317_CR9","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.3748\/wjg.v11.i34.5392","volume":"14","author":"VK Wong","year":"2005","unstructured":"Wong VK  et al. (2005) Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy. World J Gastroenterol 14: 5392\u20135393","journal-title":"World J Gastroenterol"},{"key":"BFncpgasthep1317_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14992020701261413","volume":"46","author":"A Piekarska","year":"2007","unstructured":"Piekarska A  et al. (2007) Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin. Int J Audiol 46: 345\u2013350","journal-title":"Int J Audiol"},{"key":"BFncpgasthep1317_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/278558a0","volume":"278","author":"MC Calvet","year":"1979","unstructured":"Calvet MC and Gresser I (1979) Interferon enhances the excitability of cultured neurons. Nature 278: 558\u2013560","journal-title":"Nature"},{"key":"BFncpgasthep1317_CR12","first-page":"97","volume":"15","author":"A Tunca","year":"2004","unstructured":"Tunca A  et al. (2004) Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report. Turk J Gastroenterol 15: 97\u201399","journal-title":"Turk J Gastroenterol"},{"key":"BFncpgasthep1317_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1017\/S0022215100142197","volume":"112","author":"G Cadoni","year":"1998","unstructured":"Cadoni G  et al. (1998) Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune\u2013microvascular pathogenesis. J Laryngol Otol 112: 962\u2013963","journal-title":"J Laryngol Otol"},{"key":"BFncpgasthep1317_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1067\/mhn.2001.112312","volume":"124","author":"MU Akyol","year":"2001","unstructured":"Akyol MU  et al. (2001) Investigation of the ototoxic effects of interferon \u03b12a on the mouse cochlea. Otolaryngol Head Neck Surg 124: 107\u2013110","journal-title":"Otolaryngol Head Neck Surg"},{"key":"BFncpgasthep1317_CR15","unstructured":"Repatriation General Hospital Pharmacy E-Bulletin: Naranjo reverse drug reaction probability scale [\n                    http:\/\/www.finlay-online.com\/albarranschoolofmedicine\/Naranjo%20Adverse\u00a0%20Drug%20Reaction%20Questionjaire.pdf\n                    \n                  ] (accessed 3 November 2008)"},{"key":"BFncpgasthep1317_CR16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archotol.1980.00790360050013","volume":"106","author":"WR Wilson","year":"1980","unstructured":"Wilson WR  et al. (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol 106: 772\u2013776","journal-title":"Arch Otolaryngol"},{"key":"BFncpgasthep1317_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archotol.133.6.582","volume":"133","author":"AE Conlin","year":"2007","unstructured":"Conlin AE  et al. (2007) Treatment of sudden sensorineural searing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg 133: 582\u2013586","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"BFncpgasthep1317_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00004836-200102000-00008","volume":"32","author":"JG McHutchison","year":"2001","unstructured":"McHutchison JG  et al. (2001) Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial. J Clin Gastroenterol 32: 133\u2013137","journal-title":"J Clin Gastroenterol"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1317","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:10:10Z","timestamp":1684440610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep1317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFncpgasthep1317"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep1317","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}